8 research outputs found
Angiogenic Factor Expression in Hepatic Cirrhosis
The pathogenesis of fibrosis in hepatic cirrhosis remains obscure. This study examines the eventual role of angiogenic factors in the fibrotic process. A series of 55 cirrhotic livers was studied for the proliferation state of fibroblasts, and the expression of vascular endothelial growth factor (VEGF), thymidine phosphorylase (TP) and the basic and acidic fibroblast growth factor (bFGF, aFGF) in both fibroblasts and hepatic cells. The angiogenic and/or fibrogenic factors VEGF, TP, bFGF, and aFGF were clearly expressed in regenerative hepatocytes, but not in fibroblasts of diffuse hepatic fibrosis. The immunohistochemical findings suggest that angiogenic factors and factors promoting oxidative stress (i.e., TP) produced by hepatocytes may contribute to the development of fibrous bands in hepatic cirrhosis
Characteristics of patients presenting to the vascular emergency department of a tertiary care hospital: a 2-year study
<p>Abstract</p> <p>Background</p> <p>The structure of health care in Greece is receiving increased attention to improve its cost-effectiveness. We sought to examine the epidemiological characteristics of patients presenting to the vascular emergency department of a Greek tertiary care hospital during a 2-year period. We studied all patients presenting to the emergency department of vascular surgery at Red Cross Hospital, Athens, Greece between 1<sup>st </sup>January 2009 and 31st December 2010.</p> <p>Results</p> <p>Overall, 2452 (49.4%) out of 4961 patients suffered from pathologies that should have been treated in primary health care. Only 2509 (50.6%) needed vascular surgical intervention.</p> <p>Conclusions</p> <p>The emergency department of vascular surgery in a Greek tertiary care hospital has to treat a remarkably high percentage of patients suitable for the primary health care level. These results suggest that an improvement in the structure of health care is needed in Greece.</p
Natural history of chronic hepatitis B virus infection in children of different ethnic origins: A cohort study with up to 12 years' follow-up in northern Greece
Aim: To investigate the mode of transmission and the natural history of
chronic hepatitis B virus (HBV) infection in children of different
ethnicities in Greece. This study was part of the Interreg I-II EC
project.
Patients and Methods: One hundred seventy-three hepatitis B surface
antigen (HBsAg)(+) carriers, median age 6.9 (5-12) y, were prospectively
followed-up for a mean period of 5.3 (1-12) y for serological markers of
HBV infection, serum alanine aminotransferase (ALT), HBV-DNA,
(x-fetoprotein levels and ultrasonography.
Results: Vertical transmission predominates (61.8%) in Moslem children
and horizontal (44%) in those born in Russia. At entry, 73 of 173
(42%) HBsAg(+) genotype D children were hepatitis B e antigen
(HBeAg)(+), ranging from 27% to 67% among ethnic groups; 55 of 173
(32%) had ALT > 2 x upper normal limit (UNL), ranging from 21% to
39%. Of 100 anti-HBe(+) children, 85 (85%) were inactive carriers.
During the follow-up period, seroconversion to anti-HBe was observed in
40 of 73 (55%) children with an annual rate of 11%; 35 of 40 (87.5%)
had biochemical remission, and 28 of 35 (80%) lost HBV-DNA. In the
anti-HBe(+) group, 27 of 100 (27%) lost HBV-DNA and 9 of 100 (9%) lost
HBsAg. The annual seroconversion rate for HBeAg was significantly lower:
in children with vertical transmission compared with horizontal (7.7%
vs 14.8%, respectively, P < 0.001) and in Muslim children compared with
both Christian children and those born in Russia (8.6% vs 12%,
respectively, P < 0.001). No differences were found among the ethnic
groups after adjusting for the mode of infection. Two of 173 children
had progression of liver disease.
Conclusions: The differences in HBeAg(+) status and seroconversion rate
among the ethnic groups are related to the time/mode of HBV infection.
The majority of children who developed anti-HBe immunity had biochemical
remission, and a substantial number of the inactive carriers lost
viremia during the observation period of up to 12 y